Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabhat K Chand

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Opinion in Psychiatry|April 7, 2009
The implications of medication development in the treatment of substance use disorders in developing countriesJagadisha Thirthalli, Prabhat K Chand
Addiction (Abingdon, England)|November 18, 2003
Megadose lorazepam dependencePrabhat K Chand, Pratima Murthy
Current Opinion in Psychiatry|April 14, 2006
Dissociative and conversion disorders: defining boundariesMohan Isaac, Prabhat K Chand
Current Opinion in Psychiatry|June 4, 2019
Treatment of substance use disorders with co-occurring severe mental health disordersPratima Murthy, Jayant Mahadevan, Prabhat K Chand
The Journal of Clinical Psychiatry|June 18, 2005
Monosymptomatic hypochondriacal psychosis: atypical presentation and response to olanzapinePrabhat K Chand, Sandip Anand, Pratima Murthy
Psychiatry and Clinical Neurosciences|May 20, 2004
Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxisPrabhat K Chand, Surendra K Mattoo, Pratap Sharan
Primary Care Companion to the Journal of Clinical Psychiatry|July 17, 2007
A case of late-onset pedophilia and response to sertralineNaren Prahlada Rao, Prabhat K Chand, Pratima Murthy
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 15, 2004
Venlafaxine-associated hypomania in unipolar depressionPrabhat K Chand, Ganjigunte S Kalyani, Pratima Murthy
Plos Medicine|October 28, 2009
Packages of care for alcohol use disorders in low- and middle-income countriesVivek Benegal, Prabhat K Chand, Isidore S Obot
American Journal of Therapeutics|January 8, 2016
Sublingual Buprenorphine-Induced Psychomimetic EffectsSahoo Saddichha, B N Subodh, Prabhat K Chand
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Opinion in Psychiatry|April 7, 2009
The implications of medication development in the treatment of substance use disorders in developing countriesJagadisha Thirthalli, Prabhat K Chand
Addiction (Abingdon, England)|November 18, 2003
Megadose lorazepam dependencePrabhat K Chand, Pratima Murthy
Current Opinion in Psychiatry|April 14, 2006
Dissociative and conversion disorders: defining boundariesMohan Isaac, Prabhat K Chand
Current Opinion in Psychiatry|June 4, 2019
Treatment of substance use disorders with co-occurring severe mental health disordersPratima Murthy, Jayant Mahadevan, Prabhat K Chand
The Journal of Clinical Psychiatry|June 18, 2005
Monosymptomatic hypochondriacal psychosis: atypical presentation and response to olanzapinePrabhat K Chand, Sandip Anand, Pratima Murthy
Psychiatry and Clinical Neurosciences|May 20, 2004
Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxisPrabhat K Chand, Surendra K Mattoo, Pratap Sharan
Primary Care Companion to the Journal of Clinical Psychiatry|July 17, 2007
A case of late-onset pedophilia and response to sertralineNaren Prahlada Rao, Prabhat K Chand, Pratima Murthy
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 15, 2004
Venlafaxine-associated hypomania in unipolar depressionPrabhat K Chand, Ganjigunte S Kalyani, Pratima Murthy
Plos Medicine|October 28, 2009
Packages of care for alcohol use disorders in low- and middle-income countriesVivek Benegal, Prabhat K Chand, Isidore S Obot
American Journal of Therapeutics|January 8, 2016
Sublingual Buprenorphine-Induced Psychomimetic EffectsSahoo Saddichha, B N Subodh, Prabhat K Chand
Pageof 3